Davis Walp

Davis Walp is the Founder and CEO with more than 25 years of experience across the life sciences manufacturer, professional services, and health information technology segments. He has a background in executive leadership and general management of healthtech startups, focusing on precision medicine, RWE data analytics, clinical/observational research, and patient engagement. Walp was an executive leader at Decision Resources Group, a global products and professional services business that provides health analytics, insights, and consulting services. He also held leadership roles at Veradigm, where he managed research offerings for CROs and pharmaceutical sponsors. At Allscripts, he led precision medicine strategy and partnership development. Additionally, Walp was responsible for product and customer strategy, client delivery, and collaborative research solutions at ConvergeHEALTH by Deloitte. He spent over a decade at Johnson & Johnson, Pfizer, and GlaxoSmithKline in strategic marketing, new product planning, and corporate development roles. Walp holds an MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester.